
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Circulating exosomal miR-92b-5p is a promising diagnostic biomarker of heart failure with reduced ejection fraction patients hospitalized for acute heart failure
Tao Wu, Yi‐Chen Chen, Yantao Du, et al.
Journal of Thoracic Disease (2018) Vol. 10, Iss. 11, pp. 6211-6220
Open Access | Times Cited: 53
Tao Wu, Yi‐Chen Chen, Yantao Du, et al.
Journal of Thoracic Disease (2018) Vol. 10, Iss. 11, pp. 6211-6220
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
Yuncong Shi, Huanji Zhang, Suli Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 201
Yuncong Shi, Huanji Zhang, Suli Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 201
The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease
Dongdong Zheng, Ming Huo, Bo Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 178
Dongdong Zheng, Ming Huo, Bo Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 178
Circulating microRNAs: Biomarkers of disease
Yudong Wu, Qian Li, Renshuai Zhang, et al.
Clinica Chimica Acta (2021) Vol. 516, pp. 46-54
Closed Access | Times Cited: 125
Yudong Wu, Qian Li, Renshuai Zhang, et al.
Clinica Chimica Acta (2021) Vol. 516, pp. 46-54
Closed Access | Times Cited: 125
Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers
Suet Yen Chong, Choon Keong Lee, Chenyuan Huang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3272-3272
Open Access | Times Cited: 107
Suet Yen Chong, Choon Keong Lee, Chenyuan Huang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3272-3272
Open Access | Times Cited: 107
Epigenetic Biomarkers in Cardiovascular Diseases
Carolina Soler‐Botija, Carolina Gálvez‐Montón, Antoni Bayés‐Genís
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 102
Carolina Soler‐Botija, Carolina Gálvez‐Montón, Antoni Bayés‐Genís
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 102
Advances in Therapeutic Applications of Extracellular Vesicles
Yiming Zhang, Yiming Dou, Liu Yang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3285-3307
Open Access | Times Cited: 25
Yiming Zhang, Yiming Dou, Liu Yang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3285-3307
Open Access | Times Cited: 25
Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis
Jung‐Yu Kan, Shen‐Liang Shih, Sheau‐Fang Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1295-1295
Open Access | Times Cited: 9
Jung‐Yu Kan, Shen‐Liang Shih, Sheau‐Fang Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1295-1295
Open Access | Times Cited: 9
Unravelling exosome paradigm: Therapeutic, diagnostic and theranostics application and regulatory consideration
Reetika Tandon, Nidhi Srivastava
Life Sciences (2025), pp. 123472-123472
Closed Access | Times Cited: 1
Reetika Tandon, Nidhi Srivastava
Life Sciences (2025), pp. 123472-123472
Closed Access | Times Cited: 1
Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta‐analysis
Reza Parvan, Milad Hosseinpour, Yousef Moradi, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 12, pp. 2212-2225
Open Access | Times Cited: 29
Reza Parvan, Milad Hosseinpour, Yousef Moradi, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 12, pp. 2212-2225
Open Access | Times Cited: 29
Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
Moza A Alzaabi, Amin Abdelsalam, Majid Alhammadi, et al.
Cardiac failure review (2024) Vol. 10
Open Access | Times Cited: 6
Moza A Alzaabi, Amin Abdelsalam, Majid Alhammadi, et al.
Cardiac failure review (2024) Vol. 10
Open Access | Times Cited: 6
Extracellular vesicles in cardiovascular disease
Chenyuan Huang, Yub Raj Neupane, Xiong Chang Lim, et al.
Advances in clinical chemistry (2020), pp. 47-95
Closed Access | Times Cited: 48
Chenyuan Huang, Yub Raj Neupane, Xiong Chang Lim, et al.
Advances in clinical chemistry (2020), pp. 47-95
Closed Access | Times Cited: 48
Research advances for exosomal miRNAs detection in biosensing: From the massive study to the individual study
Yuan Wu, Ye Zhang, Xiaohe Zhang, et al.
Biosensors and Bioelectronics (2020) Vol. 177, pp. 112962-112962
Closed Access | Times Cited: 46
Yuan Wu, Ye Zhang, Xiaohe Zhang, et al.
Biosensors and Bioelectronics (2020) Vol. 177, pp. 112962-112962
Closed Access | Times Cited: 46
The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease
Lee Ohayon, Xinyi Zhang, Partha Dutta
Pharmacological Research (2021) Vol. 170, pp. 105692-105692
Open Access | Times Cited: 36
Lee Ohayon, Xinyi Zhang, Partha Dutta
Pharmacological Research (2021) Vol. 170, pp. 105692-105692
Open Access | Times Cited: 36
The microRNA Expression Profiling in Heart Failure: A Systematic Review and Meta-Analysis
Nannan Shen, Jialiang Wang, Yongping Fu
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Nannan Shen, Jialiang Wang, Yongping Fu
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?
Haorong Chen, Hanbo Yao, Jiaxin Chi, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 15
Haorong Chen, Hanbo Yao, Jiaxin Chi, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 15
Multi-omics analysis identified extracellular vesicles as biomarkers for cardiovascular diseases
Meng Ke, Fanqi Meng, Yuan Wu, et al.
Talanta (2024) Vol. 280, pp. 126710-126710
Closed Access | Times Cited: 5
Meng Ke, Fanqi Meng, Yuan Wu, et al.
Talanta (2024) Vol. 280, pp. 126710-126710
Closed Access | Times Cited: 5
Extracellular vesicles in cardiovascular homeostasis and disease: potential role in diagnosis and therapy.
Junjie Xiao, Joost P. G. Sluijter
PubMed (2025)
Closed Access
Junjie Xiao, Joost P. G. Sluijter
PubMed (2025)
Closed Access
Role of Exosomal miRNAs in Heart Failure
Ruicong Xue, Weiping Tan, Yuzhong Wu, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 34
Ruicong Xue, Weiping Tan, Yuzhong Wu, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 34
Circulating exosomalmicroRNAs as emerging non‐invasive clinical biomarkers in heart failure: Mega bio‐roles of a nano bio‐particle
Runfa Zhou, Leiyan Wang, Gang Zhao, et al.
IUBMB Life (2020) Vol. 72, Iss. 12, pp. 2546-2562
Open Access | Times Cited: 33
Runfa Zhou, Leiyan Wang, Gang Zhao, et al.
IUBMB Life (2020) Vol. 72, Iss. 12, pp. 2546-2562
Open Access | Times Cited: 33
The Role of microRNAs in Heart Failure: A Systematic Review
Ana Peterlin, Karolina Počivavšek, Daniel Petrovič, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 33
Ana Peterlin, Karolina Počivavšek, Daniel Petrovič, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 33
Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach
Liliana Moreira‐Costa, António S. Barros, André P. Lourenço, et al.
Proteomes (2021) Vol. 9, Iss. 1, pp. 8-8
Open Access | Times Cited: 27
Liliana Moreira‐Costa, António S. Barros, André P. Lourenço, et al.
Proteomes (2021) Vol. 9, Iss. 1, pp. 8-8
Open Access | Times Cited: 27
Inflammation in Heart Failure—Future Perspectives
Alexandru Mircea Arvunescu, Ruxandra Florentina Ionescu, Sanda Maria Creţoiu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7738-7738
Open Access | Times Cited: 12
Alexandru Mircea Arvunescu, Ruxandra Florentina Ionescu, Sanda Maria Creţoiu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7738-7738
Open Access | Times Cited: 12
Exo-miR-144-3p as a promising diagnostic biomarker for depressive symptoms in heart failure
Ruting Wang, Kai Huang, Yuehua Feng, et al.
Neurobiology of Disease (2024), pp. 106415-106415
Open Access | Times Cited: 4
Ruting Wang, Kai Huang, Yuehua Feng, et al.
Neurobiology of Disease (2024), pp. 106415-106415
Open Access | Times Cited: 4
Circulating exosomal MicroRNAs: New non-invasive biomarkers of non-communicable disease
Jorge Armando Jiménez-Ávalos, Juan Carlos Fernández-Macías, Ana Karen González-Palomo
Molecular Biology Reports (2020) Vol. 48, Iss. 1, pp. 961-967
Closed Access | Times Cited: 27
Jorge Armando Jiménez-Ávalos, Juan Carlos Fernández-Macías, Ana Karen González-Palomo
Molecular Biology Reports (2020) Vol. 48, Iss. 1, pp. 961-967
Closed Access | Times Cited: 27
Circulating miR‐19b‐3p as a Novel Prognostic Biomarker for Acute Heart Failure
Yang Su, Yuxi Sun, Yansong Tang, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 20
Open Access | Times Cited: 26
Yang Su, Yuxi Sun, Yansong Tang, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 20
Open Access | Times Cited: 26